Medical research body advises conditional use of puberty blockers for young people

Australia's National Health and Medical Research Council (NHMRC) has advised that puberty blockers are appropriate for gender-affirming care of young people in certain circumstances. The advice appears in interim national clinical practice guidelines, meaning provisional ones, and follows a year-long review of international evidence. The Guardian reported the release.
The federal government commissioned the council to develop the advice in response to bans in public hospitals in Queensland and the Northern Territory. The NHMRC is an independent statutory agency, which means it was set up under law, and it is funded by the Commonwealth.
The council explicitly rejected what it called the "wait and see" model. It stated that withholding care can affect a young person's physical and mental health, wellbeing and ability to function.
The guidelines also state that gender incongruence is not a mental health disorder. They do not require a child to be distressed in order to be treated for gender incongruence.
Puberty blockers are not new. They have been used to treat precocious puberty, a condition in which puberty starts unusually early, since the 1970s. They have been used in gender-affirming care since the 1990s.


